Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Elisaf

Showing results (31-40 of 248) with videos related to

Pageof 25
Sort By:
Journal of Hypertension|February 1, 2002
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and goutEvagelos Liberopoulos, Dimitris Christides, Moses Elisaf
World Journal of Diabetes|January 1, 2014
Effect of hypolipidemic treatment on glycemic profile in patients with mixed dyslipidemiaAnastazia Kei, Evangelos Liberopoulos, Moses Elisaf
Expert Opinion on Biological Therapy|December 11, 2014
Proprotein convertase subtilisin kexin 9 inhibitors: next generation in lipid-lowering therapyHaralampos Milionis, George Liamis, Moses Elisaf
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2004
Apolipoprotein E and renal diseaseEvagelos Liberopoulos, Kostas Siamopoulos, Moses Elisaf
Expert Opinion on Pharmacotherapy|August 3, 2018
Pharmacological management of hyponatremiaTheodosios Filippatos, Moses Elisaf, George Liamis
Journal of Clinical Hypertension (Greenwich, Conn.)|October 9, 2018
Arterial damage and cognitive impairment in patients with chronic kidney diseaseDespina Karasavvidou, Rigas Kalaitzidis, Moses Elisaf
The Open Cardiovascular Medicine Journal|June 7, 2011
Dyslipidemia associated with chronic kidney diseaseVasilis Tsimihodimos, Zoi Mitrogianni, Moses Elisaf
International Journal of Cardiology|September 17, 2017
Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillationFotios Barkas, Moses Elisaf, Evangelos Liberopoulos
Disease Markers|April 5, 2019
Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and DiabetesEliza Christopoulou, Moses Elisaf, Theodosios Filippatos
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 28, 2014
Primary prevention of cardiovascular disease in Greece: Greek results of the EURIKA studyMoses Elisaf, Emmanouil Tzouvelekis, Nikos Nikas, et al.
Pageof 25

Showing results (31-40 of 248) with videos related to

Sort By:
Pageof 25
Journal of Hypertension|February 1, 2002
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and goutEvagelos Liberopoulos, Dimitris Christides, Moses Elisaf
World Journal of Diabetes|January 1, 2014
Effect of hypolipidemic treatment on glycemic profile in patients with mixed dyslipidemiaAnastazia Kei, Evangelos Liberopoulos, Moses Elisaf
Expert Opinion on Biological Therapy|December 11, 2014
Proprotein convertase subtilisin kexin 9 inhibitors: next generation in lipid-lowering therapyHaralampos Milionis, George Liamis, Moses Elisaf
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2004
Apolipoprotein E and renal diseaseEvagelos Liberopoulos, Kostas Siamopoulos, Moses Elisaf
Expert Opinion on Pharmacotherapy|August 3, 2018
Pharmacological management of hyponatremiaTheodosios Filippatos, Moses Elisaf, George Liamis
Journal of Clinical Hypertension (Greenwich, Conn.)|October 9, 2018
Arterial damage and cognitive impairment in patients with chronic kidney diseaseDespina Karasavvidou, Rigas Kalaitzidis, Moses Elisaf
The Open Cardiovascular Medicine Journal|June 7, 2011
Dyslipidemia associated with chronic kidney diseaseVasilis Tsimihodimos, Zoi Mitrogianni, Moses Elisaf
International Journal of Cardiology|September 17, 2017
Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillationFotios Barkas, Moses Elisaf, Evangelos Liberopoulos
Disease Markers|April 5, 2019
Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and DiabetesEliza Christopoulou, Moses Elisaf, Theodosios Filippatos
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 28, 2014
Primary prevention of cardiovascular disease in Greece: Greek results of the EURIKA studyMoses Elisaf, Emmanouil Tzouvelekis, Nikos Nikas, et al.
Pageof 25